GranuFlo, manufactured by Fresenius Medical Care, is a substance used to neutralize the buildup of acid in the blood during hemodialysis. In response to reports of heart attack and cardiac death in patients, the U.S. Food and Drug Administration (FDA) issued a product recall notice for GranuFlo and its sister product NaturaLyte in June 2012. If you or a family member has suffered adverse effects from the use of GranuFlo or NaturaLyte, you may be eligible for compensation for your financial losses and suffering. Experienced Drug Recall Attorneys Pribanic & Pribanic in Pittsburgh, Pennsylvania, is a team of attorneys that provides results-oriented representation for victims of defective products. We carefully investigate each case, document our client's economic and noneconomic losses and seek full compensation in settlement negotiations or at trial. Pribanic & Pribanic is committed to obtaining the best possible result for every client. GranuFlo Side Effects GranuFlo can be highly effective, in that it contains a higher concentration of an acid-neutralizing agent that converts to bicarbonate in the blood. However, this higher concentration can damage the heart. In addition, some doctors, unaware of the additional bicarbonate contribution of GranuFlo, have prescribed even more bicarbonates to hemodialysis patients. Some of the adverse effects associated with the use of GranuFlo and NaturaLyte include:
- Heart attack
- Cardiopulmonary arrest
- Sudden cardiac death
- Rapid heartbeat
- Heart arrhythmia
- Kidney failure